Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Poole

Showing results (821-830 of 840) with videos related to

Pageof 84
Sort By:
Seminars in Arthritis and Rheumatism|September 26, 2022
Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung diseaseAustin M Wheeler, Joshua F Baker, Jill A Poole, et al.
Journal of the American College of Cardiology|February 4, 2012
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trialStephan von Haehling, Joerg C Schefold, Ewa A Jankowska, et al.
International Immunopharmacology|August 30, 2021
The impact of airborne endotoxin exposure on rheumatoid arthritis-related joint damage, autoantigen expression, autoimmunity, and lung diseaseTed R Mikuls, Rohit Gaurav, Geoffrey M Thiele, et al.
American Heart Journal|March 27, 2007
A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathyFernando A Botoni, Philip A Poole-Wilson, Antonio L P Ribeiro, et al.
Rheumatology (Oxford, England)|November 6, 2024
MUC5B Promoter Variant and Survival in Rheumatoid Arthritis-Associated Interstitial Lung DiseaseJacob Klein, Austin Wheeler, Joshua F Baker, et al.
Rheumatology (Oxford, England)|October 9, 2023
Serum alarmins and the risk of incident interstitial lung disease in rheumatoid arthritisJill A Poole, Bryant R England, Harlan Sayles, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2024
Plasma Matrix Metalloproteinase Concentrations and Risk of Interstitial Lung Disease in a Prospective Rheumatoid Arthritis CohortBrent A Luedders, Austin M Wheeler, Dana P Ascherman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 20, 2024
Antibodies to Malondialdehyde-Acetaldehyde Adduct Are Associated With Prevalent and Incident Rheumatoid Arthritis-Associated Interstitial Lung Disease in US VeteransNozima Aripova, Geoffrey M Thiele, Michael J Duryee, et al.
International Immunopharmacology|December 12, 2023
Expansion of distinct peripheral blood myeloid cell subpopulations in patients with rheumatoid arthritis-associated interstitial lung diseaseJill A Poole, Kathryn E Cole, Geoffrey M Thiele, et al.
European Heart Journal|January 12, 2005
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)Marcus D Flather, Marcelo C Shibata, Andrew J S Coats, et al.
Pageof 84

Showing results (821-830 of 840) with videos related to

Sort By:
Pageof 84
Seminars in Arthritis and Rheumatism|September 26, 2022
Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung diseaseAustin M Wheeler, Joshua F Baker, Jill A Poole, et al.
Journal of the American College of Cardiology|February 4, 2012
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trialStephan von Haehling, Joerg C Schefold, Ewa A Jankowska, et al.
International Immunopharmacology|August 30, 2021
The impact of airborne endotoxin exposure on rheumatoid arthritis-related joint damage, autoantigen expression, autoimmunity, and lung diseaseTed R Mikuls, Rohit Gaurav, Geoffrey M Thiele, et al.
American Heart Journal|March 27, 2007
A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathyFernando A Botoni, Philip A Poole-Wilson, Antonio L P Ribeiro, et al.
Rheumatology (Oxford, England)|November 6, 2024
MUC5B Promoter Variant and Survival in Rheumatoid Arthritis-Associated Interstitial Lung DiseaseJacob Klein, Austin Wheeler, Joshua F Baker, et al.
Rheumatology (Oxford, England)|October 9, 2023
Serum alarmins and the risk of incident interstitial lung disease in rheumatoid arthritisJill A Poole, Bryant R England, Harlan Sayles, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2024
Plasma Matrix Metalloproteinase Concentrations and Risk of Interstitial Lung Disease in a Prospective Rheumatoid Arthritis CohortBrent A Luedders, Austin M Wheeler, Dana P Ascherman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 20, 2024
Antibodies to Malondialdehyde-Acetaldehyde Adduct Are Associated With Prevalent and Incident Rheumatoid Arthritis-Associated Interstitial Lung Disease in US VeteransNozima Aripova, Geoffrey M Thiele, Michael J Duryee, et al.
International Immunopharmacology|December 12, 2023
Expansion of distinct peripheral blood myeloid cell subpopulations in patients with rheumatoid arthritis-associated interstitial lung diseaseJill A Poole, Kathryn E Cole, Geoffrey M Thiele, et al.
European Heart Journal|January 12, 2005
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)Marcus D Flather, Marcelo C Shibata, Andrew J S Coats, et al.
Pageof 84